TDAC
Translational Development Acquisition Corp.
Price Chart
Latest Quote
$10.75
+0.01 (+0.09%)
Current Price
| Previous Close | $10.74 |
| Open | $10.74 |
| Day High | $10.75 |
| Day Low | $10.73 |
| Volume | 3,860 |
Stock Information
| Shares Outstanding | 21.91M |
| Total Debt | $500K |
| Cash Equivalents | $25K |
| Net Income | $6.21M |
| Sector | Financial Services |
| Industry | Shell Companies |
| Market Cap | $235.51M |
| P/E Ratio | 38.39 |
| EPS (TTM) | $0.28 |
| Exchange | NGM |
đ Comprehensive Analysis
Company Data
| Enterprise Value | $235.54M |
| Income | $6.21M |
| Book/sh | $-1.47 |
| Cash/sh | $0.00 |
Financial Ratios
| Quick Ratio | 0.03 |
| Current Ratio | 0.09 |
| EPS Growth TTM | -10.10% |
Returns & Margins
| ROA | -0.31% |
Ownership
| Institutional Ownership | 79.72% |
| Insider & Institutional transactions data not available | |
Valuation Ratios
| P/B | -7.34 |
Analyst Data
| Recommendation | none |
Technical Indicators
| SMA20 | $10.72 |
| SMA50 | $10.67 |
| SMA200 | $10.52 |
| RSI | 50.00 |
| ATR | 0.0420 |
| Shares Float | 14.70M |
| Short Float | 0.01% |
| Short Ratio | 0.01 |
| Rel Volume | 0.01 |
Performance History
| Week | +0.28% |
| Month | +1.03% |
| Quarter | +1.90% |
| 6 Months | +2.87% |
| YTD | +2.48% |
| Year | +4.67% |
| 10 Years | +7.39% |
Stock Score:
â Premium
Based on debt, profitability, growth, and cash flow metrics
â Premium Feature
Sign up for free to view detailed scoring breakdown â premium is free during our trial period!
Recent Price History
| Date | Close | Volume |
|---|---|---|
| 2026-06-18 | $10.75 | 3,860 |
| 2026-06-17 | $10.73 | 12,400 |
| 2026-06-16 | $10.73 | 13,800 |
| 2026-06-15 | $10.73 | 67,600 |
| 2026-06-12 | $10.72 | 307,200 |
| 2026-06-11 | $10.72 | 53,900 |
| 2026-06-10 | $10.72 | 31,600 |
| 2026-06-09 | $10.72 | 34,500 |
| 2026-06-08 | $10.76 | 344,700 |
| 2026-06-05 | $10.74 | 27,400 |
| 2026-06-04 | $10.75 | 530,600 |
| 2026-06-03 | $10.74 | 619,800 |
| 2026-06-02 | $10.75 | 15,900 |
| 2026-06-01 | $10.75 | 84,300 |
| 2026-05-29 | $10.75 | 225,700 |
| 2026-05-28 | $10.76 | 304,200 |
| 2026-05-27 | $10.73 | 3,119,100 |
| 2026-05-26 | $10.64 | 0 |
| 2026-05-22 | $10.64 | 4,400 |
| 2026-05-21 | $10.66 | 16,600 |
| 2026-05-20 | $10.64 | 0 |
| 2026-05-19 | $10.64 | 6,900 |
About Translational Development Acquisition Corp.
Translational Development Acquisition Corp. does not have significant operations. The company intends to effect a merger, amalgamation, share exchange, asset acquisition, share purchase, reorganization, or similar business combination with one or more businesses. Translational Development Acquisition Corp. was incorporated in 2022 and is based in New York, New York.
Period:
Loading...
Income Statement (Annual)
| Metric | 2025-12-31 | 2024-12-31 | 2023-12-31 |
|---|---|---|---|
| Revenue | |||
| Total Revenue | $0 | $0 | $0 |
| Operating Revenue | $0 | $0 | $0 |
| Expenses | |||
| Total Expenses | $944,538 | $196,358 | $485,550 |
| Other Income Expense | $7,306,965 | $125,346 | - |
| Operating Expense | $944,538 | $196,358 | $485,550 |
| General And Administrative Expense | $944,538 | $196,358 | $485,550 |
| Income & Earnings | |||
| Net Income From Continuing Operation Net Minority Interest | $6,362,427 | $-71,012 | $-485,550 |
| Normalized Income | $589,925 | $-196,358 | $-485,550 |
| Net Income From Continuing And Discontinued Operation | $6,362,427 | $-71,012 | $-485,550 |
| Total Operating Income As Reported | $-944,538 | $-196,358 | $-485,550 |
| Net Income Common Stockholders | $6,362,427 | $-71,012 | $-485,550 |
| Net Income | $6,362,427 | $-71,012 | $-485,550 |
| Net Income Including Noncontrolling Interests | $6,362,427 | $-71,012 | $-485,550 |
| Net Income Continuous Operations | $6,362,427 | $-71,012 | $-485,550 |
| Pretax Income | $6,362,427 | $-71,012 | $-485,550 |
| Operating Income | $-944,538 | $-196,358 | $-485,550 |
| Per Share | |||
| Diluted EPS | $0.29 | $-0.02 | $-0.11 |
| Basic EPS | $0.29 | $-0.02 | $-0.11 |
| Other | |||
| Tax Effect Of Unusual Items | $1,534,463 | $0 | $0 |
| Tax Rate For Calcs | $0 | $0 | $0 |
| Normalized EBITDA (Bullshit earnings) | $-8,251,503 | $-321,704 | $-485,550 |
| Total Unusual Items | $7,306,965 | $125,346 | - |
| Total Unusual Items Excluding Goodwill | $7,306,965 | $125,346 | - |
| EBITDA (Bullshit earnings) | $-944,538 | $-196,358 | $-485,550 |
| EBIT | $-944,538 | $-196,358 | $-485,550 |
| Diluted Average Shares | $21,907,500 | $19,050,000 | $19,050,000 |
| Basic Average Shares | $21,907,500 | $4,392,473 | $4,392,473 |
| Diluted NI Availto Com Stockholders | $6,362,427 | $-71,012 | $-485,550 |
| Gain On Sale Of Security | $7,306,965 | $125,346 | - |
| Selling General And Administration | $944,538 | $196,358 | $485,550 |
| Other Gand A | $944,538 | $196,358 | $485,550 |
Fetched: 2026-06-16
Balance Sheet (Annual)
| Metric | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 |
|---|---|---|---|---|
| Assets | ||||
| Net Tangible Assets | $175,115,203 | $168,752,776 | $-507,658 | $-22,108 |
| Total Assets | $181,696,776 | $175,000,579 | $2,021 | $437,235 |
| Total Non Current Assets | $181,657,311 | $174,350,346 | $0 | $383,010 |
| Other Non Current Assets | $181,657,311 | $174,350,346 | - | - |
| Current Assets | $39,465 | $650,233 | $2,021 | $54,225 |
| Prepaid Assets | $9,678 | $212,059 | $0 | $52,000 |
| Cash Cash Equivalents And Short Term Investments | $29,787 | $438,174 | $2,021 | $2,225 |
| Cash And Cash Equivalents | $29,787 | $438,174 | $2,021 | $2,225 |
| Cash Financial | $29,787 | $438,174 | $2,021 | $2,225 |
| Non Current Deferred Assets | - | - | $0 | $383,010 |
| Debt | ||||
| Net Debt | $170,213 | - | $345,479 | $256,775 |
| Total Debt | $200,000 | - | $347,500 | $259,000 |
| Current Debt And Capital Lease Obligation | $200,000 | - | $347,500 | $259,000 |
| Current Debt | $200,000 | - | $347,500 | $259,000 |
| Other Current Borrowings | $200,000 | - | $347,500 | $259,000 |
| Liabilities | ||||
| Total Liabilities Net Minority Interest | $6,581,573 | $6,247,803 | $509,679 | $459,343 |
| Total Non Current Liabilities Net Minority Interest | $6,037,500 | $6,037,500 | $0 | $-50 |
| Non Current Deferred Liabilities | $6,037,500 | $6,037,500 | $0 | - |
| Current Liabilities | $544,073 | $210,303 | $509,679 | $459,393 |
| Payables And Accrued Expenses | $344,073 | $210,303 | $162,179 | $200,393 |
| Payables | $269,073 | $18,189 | $1,252 | - |
| Accounts Payable | $162,311 | $16,189 | $1,252 | - |
| Equity | ||||
| Common Stock Equity | $175,115,203 | $168,752,776 | $-507,658 | $-22,108 |
| Total Equity Gross Minority Interest | $175,115,203 | $168,752,776 | $-507,658 | $-22,108 |
| Stockholders Equity | $175,115,203 | $168,752,776 | $-507,658 | $-22,108 |
| Retained Earnings | $-6,542,574 | $-5,598,036 | $-532,658 | $-47,108 |
| Other | ||||
| Ordinary Shares Number | $21,907,500 | $21,907,500 | $19,657,500 | $19,657,500 |
| Share Issued | $21,907,500 | $21,907,500 | $19,657,500 | $19,657,500 |
| Tangible Book Value | $175,115,203 | $168,752,776 | $-507,658 | $-22,108 |
| Invested Capital | $175,315,203 | $168,752,776 | $-160,158 | $236,892 |
| Working Capital | $-504,608 | $439,930 | $-507,658 | $-405,168 |
| Total Capitalization | $175,115,203 | $168,752,776 | $-507,658 | $-22,108 |
| Additional Paid In Capital | $0 | $0 | $24,534 | $24,534 |
| Capital Stock | $181,657,777 | $174,350,812 | $466 | $466 |
| Common Stock | $181,657,777 | $174,350,812 | $466 | $466 |
| Preferred Stock | $0 | $0 | $0 | $0 |
| Current Accrued Expenses | $75,000 | $192,114 | $160,927 | $200,393 |
| Dueto Related Parties Current | $106,762 | $2,000 | $0 | - |
Fetched: 2026-06-16
Cash Flow Statement (Annual)
| Metric | 2025-12-31 | 2024-12-31 | 2023-12-31 |
|---|---|---|---|
| Free Cash Flow | |||
| Free Cash Flow | $-608,387 | $-851,446 | $-204 |
| Operating Activities | |||
| Operating Cash Flow | $-608,387 | $-851,446 | $-204 |
| Cash Flow From Continuing Operating Activities | $-608,387 | $-851,446 | $-204 |
| Operating Gains Losses | $-7,306,965 | $-125,346 | - |
| Investing Activities | |||
| Investing Cash Flow | $0 | $-174,225,000 | $0 |
| Cash Flow From Continuing Investing Activities | $0 | $-174,225,000 | $0 |
| Net Other Investing Changes | - | $-174,225,000 | - |
| Financing Activities | |||
| Issuance Of Capital Stock | $0 | $169,050,000 | $0 |
| Financing Cash Flow | $200,000 | $175,512,599 | $0 |
| Cash Flow From Continuing Financing Activities | $200,000 | $175,512,599 | $0 |
| Net Common Stock Issuance | $0 | $169,050,000 | $0 |
| Common Stock Issuance | $0 | $169,050,000 | $0 |
| Net Other Financing Charges | - | $-218,941 | - |
| Other | |||
| Repayment Of Debt | $0 | $-800,000 | $0 |
| Issuance Of Debt | $200,000 | $406,540 | $0 |
| End Cash Position | $29,787 | $438,174 | $2,021 |
| Beginning Cash Position | $438,174 | $2,021 | $2,225 |
| Changes In Cash | $-408,387 | $436,153 | $-204 |
| Proceeds From Stock Option Exercised | $0 | $7,075,000 | $0 |
| Net Issuance Payments Of Debt | $200,000 | $-393,460 | $0 |
| Net Short Term Debt Issuance | $0 | $-800,000 | $0 |
| Short Term Debt Payments | $0 | $-800,000 | $0 |
| Net Long Term Debt Issuance | $200,000 | $406,540 | - |
| Long Term Debt Issuance | $200,000 | $406,540 | - |
| Change In Working Capital | $336,151 | $-659,807 | $3,006 |
| Change In Payables And Accrued Expense | $133,770 | $-447,748 | $1,006 |
| Change In Payable | $133,770 | $-447,748 | $1,006 |
| Change In Account Payable | $29,008 | $-449,748 | $1,006 |
| Change In Prepaid Assets | $202,381 | $-212,059 | $2,000 |
| Gain Loss On Investment Securities | $-7,306,965 | $-125,346 | - |
| Net Income From Continuing Operations | $6,362,427 | $-71,012 | $-485,550 |
| Short Term Debt Issuance | - | $406,540 | $0 |
| Change In Receivables | - | $0 | $0 |
| Other Non Cash Items | - | $4,719 | - |
| Asset Impairment Charge | - | $0 | $482,340 |
| Change In Accrued Expense | - | - | $1,006 |
Fetched: 2026-06-16